Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML).
https://t.co/KAXArCd7Fp
Excited to share our preprint (manuscript in review): TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.
@UCSFCancer
https://t.co/e7obMjYF9q
Excited to share that our work was published in
@JCI_insight! We developed an inducible Ras isogenic cell line to provide insights into Raf activation. https://t.co/jyty9yakiw. @UCSFCancer@theNCI.
Last night, at the @StBaldricks event during the #COGFall2023Meeting, Todd Alonzo Braved the Shave for the 7th time! It's not too late to donate through Todd's page to help conquer kids' cancer: https://t.co/hr0RfoCIC5
Excited to share about our contribution to a recent publication in @JClinicalInvest by the Meshinchi Lab. Targeting FOLR1 in CBFA2T3-GLIS2 AML. Using our computational pipeline to generate candidates, we are investigating promising immunotherapy targets.
https://t.co/zrybDFEvwu
Excited to share that our work was published in @NatureComms! We combined a leukemia stem cell signature with established cytomolecular risk factors in AML to build a more robust and informed relapse prediction model.
https://t.co/pUW0ENsC5C